Cardiogenic shock and acute kidney injury: the rule rather than the exception.
Acute kidney injury
Cardiogenic shock
Heart failure
Outcome
Replacement therapy
Journal
Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
accepted:
23
09
2020
pubmed:
3
10
2020
medline:
15
12
2021
entrez:
2
10
2020
Statut:
ppublish
Résumé
Cardiogenic shock (CS) is a life-threatening condition of poor end-organ perfusion, caused by any cardiovascular disease resulting in a severe depression of cardiac output. Despite recent advances in replacement therapies, the outcome of CS is still poor, and its management depends more on empirical decisions rather than on evidence-based strategies. By its side, acute kidney injury (AKI) is a frequent complication of CS, resulting in the onset of a cardiorenal syndrome. The combination of CS with AKI depicts a worse clinical scenario and holds a worse prognosis. Many factors can lead to acute renal impairment in the setting of CS, either for natural disease progression or for iatrogenic causes. This review aims at collecting the current evidence-based acknowledgments in epidemiology, pathophysiology, clinical features, diagnosis, and management of CS with AKI. We also attempted to highlight the major gaps in evidence as well as to point out possible strategies to improve the outcome.
Identifiants
pubmed: 33006038
doi: 10.1007/s10741-020-10034-0
pii: 10.1007/s10741-020-10034-0
pmc: PMC8024234
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
487-496Références
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline (2017) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 136:e232–e268
pubmed: 28923988
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, Picard MH, Menegus MA, Boland J, Dzavik V, Thompson CR, Wong SC, Steingart R, Forman R, Aylward PE, Godfrey E, Desvigne-Nickens P, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634
pubmed: 10460813
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
pubmed: 27206819
Kidney Disease: Improving Global Outcomes (KDIGO) (2012) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138
Chua HR, Glassford N, Bellomo R (2012) Acute kidney injury after cardiac arrest. Resuscitation. 83:721–727
pubmed: 22155699
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539
pubmed: 19007588
Reynolds HR, Hochman JS (2008) Cardiogenic shock: current concepts and improving outcomes. Circulation. 117:686–697
pubmed: 18250279
Khan I, Dar MH, Khan A, Iltaf K, Khan S, Falah SF (2017) Frequency of acute kidney injury and its short-term effects after acute myocardial infarction. J Pak Med Assoc 67:1693–1697
pubmed: 29171562
Adegbala O, Inampudi C, Adejumo A et al (2019) Characteristics and outcomes of patients with cardiogenic shock utilizing hemodialysis for acute kidney injury. Am J Cardiol 123:1816–1821
pubmed: 30967283
Lauridsen MD, Gammelager H, Schmidt M (2015) Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. Crit Care 19:452
pubmed: 26715162
pmcid: 4699352
Vallabhajosyula S, Dunlay SM, Barsness GW, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS, Kashani K (2019) Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock. PLoS One 14:e0222894
pubmed: 31532793
pmcid: 6750602
Ho HH, Ong HA, Arasaratnam P, Ooi YW, Tan J, Loh KK, Foo D, Jafary FH, Ong PJL (2014) Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention. Int J Cardiol Heart Vessel 3:88–89
pubmed: 29450180
pmcid: 5801433
Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P (2002) Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 112:115–119
pubmed: 11835949
Vallabhajosyula S, Ya'Qoub L, Dunlay SM (2019) Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock. ESC Heart Fail 6:874–877
pubmed: 31271517
pmcid: 6676281
Aimo A, Vergaro G, Barison A, Maffei S, Borrelli C, Morrone D, Cameli M, Palazzuoli A, Ambrosio G, Coiro S, Savino K, Cerbai E, Marcucci R, Pedrinelli R, Padeletti L, Passino C, Emdin M (2018) Sex-related differences in chronic heart failure. Int J Cardiol 255:145–151
pubmed: 29425552
Li SY, Yang WC, Chuang CL (2014) Effect of early and intensive continuous venovenous hemofiltration on patients with cardiogenic shock and acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg 148:1628–1633
pubmed: 24929801
Viswanathan G, Scott G (2011) The cardiorenal syndrome: making the connection. Int J Nephrol 2011:1–10
van den Akker JPC, Bakker J, Groeneveld ABJ, den Uil CA (2019) Risk indicators for acute kidney injury in cardiogenic shock. J Crit Care 50:11–16
pubmed: 30465893
Cameli M, Pastore MC, Henein MY, Mondillo S (2019) The left atrium and the right ventricle: two supporting chambers to the failing left ventricle. Heart Fail Rev 24:661–669
pubmed: 31025236
Alho A, Jäättelä A, Lahdensuu M, Rokkanen P, Avikainen V, Karaharju E, Tervo T, Lepistö P (1977) Catecholamines in shock. Ann Clin Res 9:157–163
pubmed: 356713
Leont'eva GV, Frolova TM, Bobkov II, Kazak LE, Sukhova ZI (1981) State of the cardiovascular and sympathetic-adrenal system in experimental cardiogenic shock. Patol Fiziol Eksp Ter 6:13–18
Karth GD (2010) Heart and kidney: the cardiorenal syndrome in cardiogenic shock. Crit Care Med 38:699–700
pubmed: 20083931
Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188e95
Fozzard HA (1992) Afterdepolarizations and triggered activity. Basic Res Cardiol 87:105–113
pubmed: 1299205
Schmucker J, Fach A, Becker M, Seide S, Bünger S, Zabrocki R, Fiehn E, Würmann-Busch B, Pohlabeln H, Günther K, Ahrens W, Hambrecht R, Wienbergen H (2018) Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction – results from the Bremen STEMI Registry. Eur Heart J Acute Cardiovasc Care 7:710–722
pubmed: 29064276
Sukhodolya T, Damjanovic D, Beyersdorf F et al (2013) Standard intra-aortic counterpulsation balloon may cause temporary occlusion of mesenterial and renal arteries. ASAIO J 59:593–599
pubmed: 24172264
Freis ED, Schnaper HW, Johnson RL, Schreiner GE (1952) Hemodynamic alterations in acute myocardial infarction, I: cardiac output, mean arterial pressure, total peripheral resistance, central and total blood volumes, venous pressure and average circulation time. J Clin Invest 31:131–140
pubmed: 14907892
pmcid: 436393
Peschel T, Schönauer M, Thiele H, Anker S, Schuler G, Niebauer J (2003) Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5:609–614
pubmed: 14607199
Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS, SHOCK Investigators (2005) SHOCK Investigators. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165:1643–1650
pubmed: 16043684
Adler C, Reuter H, Seck C, Hellmich M, Zobel C (2013) Fluid therapy and acute kidney injury in cardiogenic shock after cardiac arrest. Resuscitation 84:194–199
pubmed: 22750662
Tarvasmäki T, Haapio M, Mebazaa A, Sionis A, Silva-Cardoso J, Tolppanen H, Lindholm MG, Pulkki K, Parissis J, Harjola VP, Lassus J, on behalf of the CardShock Study Investigators (2018) Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality. Eur J Heart Fail 20:572–581
pubmed: 28960633
McCullough PA, Bouchard J, Waikar SS et al (2013) Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative. Contrib Nephrol 182:5–12
pubmed: 23689652
Fuernau G, Poenisch C, Eitel I, Denks D, de Waha S, Pöss J, Heine GH, Desch S, Schuler G, Adams V, Werdan K, Zeymer U, Thiele H (2015) Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol 191:159–166
pubmed: 25965624
Fabbian F, De Giorgi A, Pala M et al (2011) Low molecular weight heparins and glomerular filtration rate: a report to be considered. Curr Vasc Pharmacol 9:693–697
pubmed: 22022829
Thiele H, Akin I, Sandri M (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377:2419–2432
pubmed: 29083953
Rubini Gimenez M, Zeymer U, Desch S et al (2020) Sex-specific management in patients with acute myocardial infarction and cardiogenic shock: a substudy of the CULPRIT-SHOCK trial. Circ Cardiovasc Interv 13:e008537
pubmed: 32151161
Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ (2010) Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 14:R169
pubmed: 20858239
pmcid: 3219266
Hevroy O, Reikeras O, Grundnes O et al (1988) Cardiovascular effects of positive end-expiratory pressure during acute left ventricular failure in dogs. Clin Physiol 8:287–301
pubmed: 3042273
Fessler HE, Brower RG, Wise RA, Permutt S (1988) Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure. J Appl Physiol 65:1244–1250
pubmed: 3053581
Peters J, Kindred MK, Robotham JL (1988) Transient analysis of cardiopulmonary interactions. II. Systolic events. J Appl Physiol 64:1518–1526
pubmed: 3378986
Grace MP, Greenbaum DM (1982) Cardiac performance in response to PEEP in patients with cardiac dysfunction. Crit Care Med 10:358–360
pubmed: 7042203
Roman-Pognuz E, Elmer J, Rittenberger JC, Guyette FX, Berlot G, de Rosa S, Peratoner A, de Arroyabe BML, Lucangelo U, Callaway CW (2019) Markers of cardiogenic shock predict persistent acute kidney injury after out of hospital cardiac arrest. Heart Lung 48:126–130
pubmed: 30470603
Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Söffker G, Lemm H, Swyter M, Wegener N, Winkler M, Carter JM, Reith S, Werdan K, Buerke M (2007) Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 35:2732–2739
pubmed: 17893627
Fang M, Cao H, Wang Z (2018) Levosimendan in patients with cardiogenic shock complicating myocardial infarction: a meta-analysis. Med Int 42:409–415
Neumann FJ, Sousa-Uva M, Ahlsson A et al (2018) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40:87–165
Christoph A, Prondzinsky R, Russ M (2008) Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute Card Care 10:49–57
pubmed: 17924229
Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LSD, van Domburg RT, Serruys PW (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30:2102–2108
pubmed: 19617601
O’Neill WW, Schreiber T, Wohns DH et al (2014) The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 27:1–11
pubmed: 24329756
Koeckert MS, Jorde UP, Naka Y, Moses JW, Takayama H (2011) Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg 26:666–668
pubmed: 22122379
Chen YC, Tsai FC, Fang JT, Yang CW (2014) Acute kidney injury in adults receiving extracorporeal membrane oxygenation. J Formos Med Assoc 113:778–785
pubmed: 24928419
Chang WW, Tsai FC, Tsai TY, Chang CH, Jenq CC, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC (2012) Predictors of mortality in patients successfully weaned from extracorporeal membrane oxygenation. PLoS One 7:e42687
pubmed: 22870340
pmcid: 3411657
Askenazi DJ, Selewski DT, Paden ML et al (2012) Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol 7:1328e36
Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, CESAR trial collaboration (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
pubmed: 19762075
Bartlett RH, Gattinoni L (2010) Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 76:534–540
pubmed: 20613694